Capella Bioscience Ltd
1 clinical trials · Sponsor
◉ Watch Capella Bioscience Ltd
| Record | Firm | Date |
|---|---|---|
| Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers (NCT05323110) | Capella Bioscience Ltd | 2022-04-14 |
Track Capella Bioscience Ltd automatically
Every clearance here is in the API, with alerts when new ones post.